Taina Vuorio
Impact in
-
- Lymphatic System and Diseases
-
- Cardiovascular Health and Disease Prevention
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- Oncology 7
- Lymphatic System and Diseases 6
- Co-authors
- Seppo Ylä‐Herttuala (12 shared papers)Tommi Heikura (2 shared papers)Haritha Samaranayake (4 shared papers)Suvi Jauhiainen (1 shared paper)Harri Nurmi (1 shared paper)Suvi E. Heinonen (1 shared paper)Miina K. Öhman (1 shared paper)Kari Alitalo (1 shared paper)
- Journals
- Scientific Reports (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Molecular Therapy (1 paper)Human Gene Therapy (1 paper)Expert Opinion on Biological Therapy (1 paper)
- Partner nations
- FinlandGermanyUnited States
In The Last Decade
Taina Vuorio
14 papers receiving 327 citations
Peers
Comparison fields: 5 of 65
- Oncology 156
- Cardiology and Cardiovascular Medicine 70
- Physiology 68
- Molecular Biology 134
- Immunology 39
Countries citing papers authored by Taina Vuorio
This map shows the geographic impact of Taina Vuorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taina Vuorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taina Vuorio more than expected).
Fields of papers citing papers by Taina Vuorio
This network shows the impact of papers produced by Taina Vuorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taina Vuorio. The network helps show where Taina Vuorio may publish in the future.
Co-authors
The 25 scholars most cited alongside Taina Vuorio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 92 | |
| 2 | 2017 | 42 | |
| 3 | 2018 | 33 | |
| 4 | 2020 | 28 | |
| 5 | 2011 | 27 | |
| 6 | 2018 | 22 | |
| 7 | 2009 | 20 | |
| 8 | 2015 | 20 | |
| 9 | 2019 | 17 | |
| 10 | 2009 | 12 | |
| 11 | 2015 | 8 | |
| 12 | 2024 | 7 | |
| 13 | 2023 | 4 | |
| 14 | 2018 | 1 |
About Taina Vuorio
Taina Vuorio is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Genetics and Surgery, having authored 14 papers that have together received 333 indexed citations. Recurring topics across this work include Lymphatic System and Diseases (6 papers), Angiogenesis and VEGF in Cancer (5 papers), Virus-based gene therapy research (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Toxic Organic Pollutants Impact (2 papers), Biotin and Related Studies (2 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Oncology (156 citations), Cardiology and Cardiovascular Medicine (70 citations), Physiology (68 citations), Molecular Biology (134 citations) and Immunology (39 citations). Taina Vuorio has collaborated with scholars based in Finland, Germany and United States. Frequent co-authors include Seppo Ylä‐Herttuala, Tommi Heikura, Haritha Samaranayake, Suvi Jauhiainen, Harri Nurmi, Suvi E. Heinonen, Miina K. Öhman, Kari Alitalo, Marius R. Robciuc and Karen S. Moulton. Their work appears in journals such as Scientific Reports, Arteriosclerosis Thrombosis and Vascular Biology, Molecular Therapy, Human Gene Therapy and Expert Opinion on Biological Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.